Evidence map›Paper›PMID 37101271›Full record

ArticleBMC pregnancy and childbirth2023

Use of pregnancy personalised follow-up in case of maternal social vulnerability to reduce prematurity and neonatal morbidity.

Simon Crequit, Gregory Bierry, Perbellini Maria, Sakina Bouali, Adelaïde Dupre La Tour, Naima Sgihouar, Bruno Renevier

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Simon CrequitService de Gynécologie Obstétrique, Centre Hospitalier Intercommunal de Montreuil, 56 Boulevard de la Boissière, 93100, Montfermeil, France. crequitsimon@gmail.com.
Gregory BierryService de Gynécologie Obstétrique, Centre Hospitalier Intercommunal de Montreuil, 56 Boulevard de la Boissière, 93100, Montfermeil, France.
Perbellini MariaService de Gynécologie Obstétrique, Centre Hospitalier Intercommunal de Montreuil, 56 Boulevard de la Boissière, 93100, Montfermeil, France.
Sakina BoualiService de Gynécologie Obstétrique, Centre Hospitalier Intercommunal de Montreuil, 56 Boulevard de la Boissière, 93100, Montfermeil, France.
Adelaïde Dupre La TourService de Gynécologie Obstétrique, Centre Hospitalier Intercommunal de Montreuil, 56 Boulevard de la Boissière, 93100, Montfermeil, France.
Naima SgihouarResponsable de L'Unité de Recherche Clinique / GHT Grand Paris Nord Est, GHI Raincy Montfermeil, 10 Rue du Général Leclerc, 93370, Montfermeil, France.
Bruno RenevierService de Gynécologie Obstétrique, Centre Hospitalier Intercommunal de Montreuil, 56 Boulevard de la Boissière, 93100, Montfermeil, France.
Groupe Hospitalier Intercommunal Le Raincy Montfermeil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSocial deprivation is a major risk factor of adverse pregnancy outcomes. Yet, there is few studies evaluating interventions aiming at reducing the impact of social vulnerability on pregnancy outcomes.

objectiveTo compare pregnancy outcomes between patients that received personalized pregnancy follow-up (PPFU) to address social vulnerability versus standard care.

methodsRetrospective comparative cohort in a single institution between 2020 and 2021. A total of 3958 women with social vulnerability that delivered a singleton after 14 gestational weeks were included, within which 686 patients had a PPFU. Social vulnerability was defined by the presence of at least one of the following characteristics: social isolation, poor or insecure housing conditions, no work-related household income, and absence of standard health insurance (these four variables were combined as a social deprivation index (SDI)), recent immigration (< 12 month), interpersonal violence during pregnancy, being handicaped or minor, addiction during pregnancy. Maternal characteristics and pregnancy outcomes were compared between patients that received PPFU versus standard care. The associations between poor pregnancy outcomes (premature birth before 37 gestational weeks (GW), premature birth before 34 GW, small for gestational age (SGA) and PPFU were tested using multivariate logistic regression and propensity score matching.

resultsAfter adjustment on SDI, maternal age, parity, body mass index, maternal origin and both high medical and obstetrical risk level before pregnancy, PPFU was an independent protective factor of premature birth before 37 gestational weeks (GW) (aOR = 0.63, 95%CI[0.46-0.86]). The result was similar for premature birth before 34 GW (aOR = 0.53, 95%CI [0.34-0.79]). There was no association between PPFU and SGA (aOR = 1.06, 95%CI [0.86 - 1.30]). Propensity score adjusted (PSa) OR for PPFU using the same variables unveiled similar results, PSaOR = 0.63, 95%CI[0.46-0.86] for premature birth before 37 GW, PSaOR = 0.52, 95%CI [0.34-0.78] for premature birth before 34 GW and PSaOR = 1.07, 95%CI [0.86 - 1.33] for SGA.

conclusionsThis work suggests that PPFU improves pregnancy outcomes and emphasizes that the detection of social vulnerability during pregnancy is a major health issue.

Indexed as

Pregnancy ComplicationsPremature BirthSocial Determinants of HealthSocial VulnerabilityFemaleFetal Growth RetardationFollow-Up StudiesHumansInfantInfant, NewbornInfant, Small for Gestational AgeMorbidityPregnancyRetrospective StudiesNeonatal morbidityNeonatal outcomesPregnancy outcomesSGASmall for gestational ageSocial deprivationSocial vulnerability

Identifiers

PMID37101271
PMCPMC10131299
OpenAlexW4367052219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.